Carillon Tower Advisers’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$7.62M Sell
49,659
-1,400
-3% -$197K 0.05% 355
2020
Q3
$6.61M Sell
51,059
-1,689
-3% -$222K 0.09% 302
2020
Q2
$5.93M Sell
52,748
-886
-2% -$90.9K 0.05% 352
2020
Q1
$4.08M Sell
53,634
-5,300
-9% -$491K 0.04% 348
2019
Q4
$5.99M Sell
58,934
-2,000
-3% -$198K 0.04% 379
2019
Q3
$6.22M Sell
60,934
-500
-0.8% -$51K 0.04% 376
2019
Q2
$7.13M Buy
61,434
+1,250
+2% +$135K 0.05% 363
2019
Q1
$6.33M Sell
60,184
-50
-0.1% -$5.61K 0.04% 368
2018
Q4
$6.79M Sell
60,234
-1,500
-2% -$185K 0.06% 338
2018
Q3
$9.98M Buy
61,734
+1,208
+2% +$171K 0.07% 337
2018
Q2
$7.2M Sell
60,526
-974
-2% -$119K 0.06% 354
2018
Q1
$7.23M Buy
+61,500
New +$6.95M 0.06% 338

Other funds holding PRLB

Carillon Tower Advisers's PRLB Position: Q4 2020 in Review

Carillon Tower Advisers reduced its Protolabs (PRLB) stake by 2.7% in Q4 2020, selling an estimated $197K and leaving 49,659 shares worth $7.62M. The position accounts for 0.05% of the portfolio, ranked #355.

Carillon Tower Advisers first reported a position in PRLB in Q1 2018 and has held it in 12 quarters since. The position peaked at $9.98M in Q3 2018. 305 funds tracked by Wall St. Rank hold PRLB as of Q4 2020.

  • Carillon Tower Advisers held 49,659 shares of Protolabs worth $7.62M as of Q4 2020.
  • Carillon Tower Advisers sold 1,400 Protolabs shares in Q4 2020, an estimated $197K.
  • Protolabs made up 0.05% of Carillon Tower Advisers's portfolio in Q4 2020, its #355 holding.
  • Carillon Tower Advisers first reported a position in Protolabs in Q1 2018 and has held it in 12 quarters since.
  • Carillon Tower Advisers's Protolabs position peaked at $9.98M in Q3 2018.
  • 305 funds tracked by Wall St. Rank held Protolabs as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.